Rankings
▼
Calendar
KLRS Q4 2019 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$180M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$19,000
Operating Income
-$10M
Net Income
-$9M
EPS (Diluted)
$-3.09
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$139M
Total Liabilities
$18M
Stockholders' Equity
$122M
Cash & Equivalents
$61M
← FY 2019
All Quarters
Q1 2020 →